Decline in 4-metre gait speed (4MGS) over 6 months is associated with mortality in IPF.

C. Nolan (London, United Kingdom), M. Maddocks (London, United Kingdom), T. Maher (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), S. Jones (London, United Kingdom), J. Walsh (London, United Kingdom), S. Wynne (London, United Kingdom), P. George (London, United Kingdom), P. Cullinan (London, United Kingdom), W. Man (London, United Kingdom)

Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Session: Biomarkers and beyond in idiopathic interstitial pneumonia
Session type: Poster Discussion
Number: 2244
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Nolan (London, United Kingdom), M. Maddocks (London, United Kingdom), T. Maher (London, United Kingdom), S. Patel (London, United Kingdom), R. Barker (London, United Kingdom), S. Jones (London, United Kingdom), J. Walsh (London, United Kingdom), S. Wynne (London, United Kingdom), P. George (London, United Kingdom), P. Cullinan (London, United Kingdom), W. Man (London, United Kingdom). Decline in 4-metre gait speed (4MGS) over 6 months is associated with mortality in IPF.. 2244

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Four metre gait speed (4MGS) predicts mortality and hospitalisation in IPF
Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Year: 2018



Performance of the 4 meter gait speed test (4MGS) compared to the 6 meters walk test (6MW) in lung pathology
Source: International Congress 2019 – Cardiopulmonary exercise testing
Year: 2019


6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015

Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)?
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


Predictors of six-minute walk distance at baseline and after three years in COPD patients
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011


Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator?
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003

The incremental shuttle walk test (ISW) in patients with bronchiectasis: Response to pulmonary rehabilitation (PR) and minimum clinically important difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Six minutes walking test (6MWT) after cardiac surgery: relation with functional impairment and depression
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001

Multivariables added to walked distance during 6-min walk test (6MWT) can predict the maximal oxigen consumption (Vo2max) in end-stage renal disease patients
Source: Eur Respir J 2004; 24: Suppl. 48, 405s
Year: 2004

Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004

Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008


Improvement of 6-minutes walking test (6MWT) and pulmonary functional status after an inpatient pulmonary rehabilitation program (PRP) in moderate-severe and severe COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004

1 Minute Sit-to-Stand Test versus 6 minutes walk test: methods of evaluating exercise capacity in COPD patients
Source: International Congress 2017 – Lung function practice in daily life
Year: 2017


Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 76s
Year: 2007

Improvements with tiotropium on endurance measured by the shuttle walking test (SWT) and on health related quality of life (HRQoL) in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 287s
Year: 2002

Reference values for the walking distance on the six-minute walk test in healthy children aged from 7 to 12 years in Brazil: The tc6minbrasil multicentric study
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018


The five-repetition sit-to-stand test (5STS) in patients with bronchiectasis: validity and reponsiveness
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


Correlation between clinically measured and wrist accelerometer derived 6 Minute Walk Distance (6MWD)
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


A comparison of the correlation of health status of the one minute sit-to-stand test (STST) and the six minute walk test (6MWT) in stable COPD
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016


The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference
Source: Eur Respir J 2014; 43: 1298-1305
Year: 2014